vindesine has been researched along with Cancer of Skin in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (40.00) | 18.7374 |
1990's | 8 (22.86) | 18.2507 |
2000's | 10 (28.57) | 29.6817 |
2010's | 2 (5.71) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Benarfa, A; Beylot-Barry, M; Dequidt, L; Ducharme, O; Dumas, PY; Gérard, E; Pham-Ledard, A | 1 |
Baldolli, A; Chuffart, M; Geffray, L; Reman, O; Verneuil, L | 1 |
Li, WF; Shao, XH; Xu, YS; Zhang, XQ | 1 |
Eigentler, TK; Ellwanger, U; Garbe, C; Gutzmer, R; Hauschild, A; Linse, R; Pföhler, C; Radny, P; Schadendorf, D; Wagner, SN | 1 |
Egberts, F; Hauschild, A; Hitschler, WN; Weichenthal, M | 1 |
Acito, L; Bacchi, M; Beretta, M; Carlini, P; Cocconi, G; Di Sarra, S; Foladore, S; Gebbia, V; Maiello, E; Marchi, M; Passalacqua, R | 1 |
Emmert, S; Haenssle, H; Kretschmer, L; Neumann, C; Zutt, M | 1 |
Egyházi, S; Hansson, J; Kreklau, EL; Lindholm, C; Ma, S; Ringborg, U; Stierner, U; Ueno, T | 1 |
Harada, T; Hayashi, I; Ishii, M; Muraoka, M | 1 |
Eigentler, TK; Garbe, C | 1 |
Hofmann, MA; Sterry, W; Trefzer, U | 1 |
Gaukroger, JM; MacKie, RM; Wilson, L | 1 |
Aigner, KR; Börger, G; Illig, L; Jungbluth, A; Link, KH; Müller, H; Ringenberg, T; Ruppel, R; Schwemmle, K; Walther, H | 1 |
Balda, BR; Jehn, U; Klövekorn, W; Wohlrab, A | 1 |
Bretaudeau, B; Giralt, E; Jouve, M; Palangie, T; Pouillart, P | 1 |
Conroy, JA; Nelimark, RA; Peterson, BA; Vosika, GJ | 1 |
Baker, LH; Costanzi, JJ; Quagliana, JM; Stephens, RL | 1 |
Algermissen, B; Czarnetzki, BM; Kohlmus, CM; Schadendorf, D; Worm, M | 1 |
Yamazaki, N | 1 |
Cavillon, C; Claude, R; Desplechain, C; Egloff, H; Franck, F; Goujon, N; Lautier, A; Plagne, R; Rigondet, G; Sale, JM | 1 |
Besnard, V; Boillot, O; Claudy, A; Euvrard, S; Faure, M; Françès, C; Kanitakis, J; Mion, F | 1 |
Brice, P; Cazals, D; Deconinck, E; Doyen, C; Gisselbrecht, C; Hamelsand, J; Molina, T; Moulonguet, I; Mounier, N; Neidhart-Berard, AM; Remenieras, L; Verola, O | 1 |
Calista, D; Landi, C; Schianchi, S | 1 |
Aamdal, S; Andersson, R; Bjelkengren, G; Ingvar, C; Jungnelius, U; Karlsson, M; Malmström, P; Mattsson, J; Ringborg, U; Stierner, U; Westberg, R; Willman, K; Wist, E | 1 |
Aoki, S; Fukuno, Y; Hayashi, S; Kawashima, M; Nagata, M; Taniguchi, S; Tominaga, M; Tsuruta, N; Yatsunami, J | 1 |
Green, JA; Iqbal, M; Marshall, E | 1 |
Deraemaecker, R; Sales, F; Vandeweyer, E | 1 |
Cartei, G; Ceschia, T; Clocchiatti, L; Fasola, G; Galletti, D; Marsilio, P; Morandini, G; Sibau, A | 1 |
Esumi, H; Hayasaka, K; Ikeda, S; Ikegawa, S; Ishihara, K; Kiyohara, Y; Obayashi, H; Saida, T; Sasaki, A | 1 |
English, JS; Lever, RS; MacKie, RM; Young, DW | 1 |
Alevizakos, N; Athanassiou, A; Bafaloukos, D; Barbounis, V; Dimitriadis, M; Pectasides, D; Varthalitis, J; Yianniotis, H | 1 |
de Garis, ST; Dische, S; Nelstrop, A; Rustin, GJ | 1 |
Carmo-Pereira, J; Costa, FO; Henriques, E | 1 |
Falkson, G; Sarli, R; Vorobiof, DA | 1 |
Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S | 1 |
3 review(s) available for vindesine and Cancer of Skin
Article | Year |
---|---|
[Interest of an intensive chemotherapy for intravascular large B cell lymphoma].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Induction Chemotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rare Diseases; Rituximab; Skin Neoplasms; Vascular Neoplasms; Vindesine | 2013 |
[Therapy of malignant melanoma at the stage of distant metastasis].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Disease Progression; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Skin Neoplasms; Temozolomide; Time Factors; Tomography, X-Ray Computed; Vindesine | 2004 |
[Chemotherapy of advanced adenocarcinoma of the skin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Humans; Male; Middle Aged; Paget Disease, Extramammary; Prognosis; Skin Neoplasms; Sweat Gland Neoplasms; Vindesine | 1993 |
8 trial(s) available for vindesine and Cancer of Skin
Article | Year |
---|---|
Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
Topics: Adult; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Skin Neoplasms; Survival Rate; Vindesine | 2008 |
Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; L-Lactate Dehydrogenase; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Nerve Growth Factors; Prospective Studies; Recombinant Proteins; Recurrence; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Vindesine | 2009 |
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Survival Rate; Tamoxifen; Treatment Outcome; Vindesine | 2003 |
Inefficacy of vindesine monotherapy in advanced stage IV malignant melanoma patients previously treated with other chemotherapeutic agents.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Female; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Salvage Therapy; Skin Neoplasms; Treatment Outcome; Vindesine | 2003 |
Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Skin Neoplasms; Treatment Outcome; Vincristine; Vindesine | 1998 |
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Nausea; Prospective Studies; Regression Analysis; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vindesine; Vomiting | 1998 |
Cytotoxic chemotherapy of disseminated cutaneous malignant melanoma--a prospective and randomized clinical trial of procarbazine, vindesine and lomustine versus procarbazine, DTIC and lomustine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Procarbazine; Prospective Studies; Random Allocation; Skin Neoplasms; Vindesine | 1986 |
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Prospective Studies; Random Allocation; Skin Neoplasms; Thrombocytopenia; Vindesine; Vomiting | 1985 |
24 other study(ies) available for vindesine and Cancer of Skin
Article | Year |
---|---|
Vindesine dexamethasone as a therapeutic option in elderly blastic plasmacytoid dendritic cell neoplasms: a monocentric experience.
Topics: Aged; Dendritic Cells; Dexamethasone; Hematologic Neoplasms; Humans; Myeloproliferative Disorders; Skin Neoplasms; Vindesine | 2021 |
Evidence based analysis of Cisplatin for treating patients with cutaneous squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Salvage Therapy; Skin Neoplasms; Survival Rate; Vindesine | 2014 |
O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Melanoma; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Polymorphism, Genetic; Skin Neoplasms; Treatment Outcome; Vindesine | 2003 |
Malignant proliferating trichilemmal tumour and CAV (cisplatin, adriamycin, vindesine) treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Cisplatin; Doxorubicin; Fatal Outcome; Female; Hair Follicle; Head and Neck Neoplasms; Humans; Middle Aged; Skin Neoplasms; Vindesine | 2004 |
Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit?
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Administration Schedule; Female; Humans; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Vindesine | 2007 |
Validation of in vitro chemosensitivity testing in malignant melanoma.
Topics: Cells, Cultured; Drug Resistance; Humans; Melanoma; Skin Neoplasms; Vinblastine; Vindesine | 1983 |
[Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dacarbazine; Humans; Leg; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Skin Neoplasms; Vinblastine; Vindesine | 1984 |
[Pilot study with vindesine as monotherapy in metastatic malignant melanomas].
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Melanoma; Middle Aged; Pilot Projects; Skin Neoplasms; Vinblastine; Vindesine | 1983 |
[Use of vindesine in lymphangitic-type cutaneous recurrence of breast cancer].
Topics: Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Lymphangitis; Skin Neoplasms; Vinblastine; Vindesine | 1983 |
Vindesine for metastatic malignant melanoma. A phase II trial.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nervous System; Skin Neoplasms; Vinblastine; Vindesine | 1983 |
Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
Topics: Adult; Aged; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nervous System Diseases; Skin Neoplasms; Thrombocytopenia; Vinblastine; Vindesine | 1984 |
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Carmustine; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluorouracil; Forecasting; Humans; In Vitro Techniques; Lymphatic Metastasis; Melanoma; Methotrexate; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction; Retrospective Studies; Skin Neoplasms; Tumor Cells, Cultured; Vindesine | 1994 |
[A case of adrenal gland metastasis of a cutaneous melanoma treated by excision with 3-year survival].
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Fatal Outcome; Follow-Up Studies; Humans; Male; Melanoma; Skin Neoplasms; Vindesine | 1996 |
Kaposi's sarcoma after liver transplantation.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Base Sequence; DNA, Viral; Female; Follow-Up Studies; Herpesviridae; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Prognosis; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Vindesine | 1996 |
Malignant blue nevus of the scalp.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Fatal Outcome; Humans; Interferon-alpha; Liver Neoplasms; Lung Neoplasms; Nevus, Blue; Scalp; Skin Neoplasms; Vindesine | 1998 |
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cisplatin; Clarithromycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Roxithromycin; Skin Neoplasms; Tumor Cells, Cultured; Vindesine | 1999 |
Ten-year survival in advanced malignant melanoma following treatment with interferon and vindesine.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Humans; Interferon-alpha; Liver Neoplasms; Male; Melanoma; Skin Neoplasms; Vindesine | 2000 |
Cutaneous malignant melanoma in children.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dacarbazine; Female; Follow-Up Studies; Humans; Infant; Male; Melanoma; Neoplasm Staging; Prognosis; Risk Factors; Skin Neoplasms; Survival Analysis; Time Factors; Treatment Outcome; Vindesine | 2000 |
Effectiveness and toxicity of "BELD" polychemotherapy in advanced malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Lomustine; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Remission Induction; Skin Neoplasms; Vindesine | 1989 |
Cisplatin combination chemotherapy in squamous cell carcinoma and adenoid cystic carcinoma of the skin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Female; Humans; Male; Middle Aged; Skin Neoplasms; Vindesine | 1989 |
The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Drug Administration Schedule; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects; Skin Neoplasms; Vinblastine; Vindesine | 1985 |
Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Skin Neoplasms; Vindesine | 1989 |
Treatment of advanced malignant melanoma with interferon alpha and etretinate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Etretinate; Female; Humans; Interferon Type I; Male; Melanoma; Middle Aged; Skin Neoplasms; Vindesine | 1988 |
Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Vindesine | 1986 |